Regeneron applauds supreme court's unanimous opinion striking down amgen's pcsk9 patent claims and supporting scientific innovation

Decision ends nearly decade-long patent dispute related to regeneron-invented praluent ® (alirocumab)
REGN Ratings Summary
REGN Quant Ranking